Xiao-Li Feng

Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol.

Sheng-yu Zhou, Xin Liu, Tao Wu, 2023, Future oncology.

Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma

Shulian Wang, Yueping Liu, H. Jing, 2024, Leukemia & lymphoma.

Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.

Yong-wen Song, Q. Zhong, S. Qi, 2024, Future oncology.